Repligen Corporation to Present at the Biocentury and Thomson Reuters 18th Annual Future Leaders in the Biotech Industry Conference

WALTHAM, Mass.--(BUSINESS WIRE)--Repligen Corporation (NASDAQ: RGEN) announced today that the Company President and Chief Executive Officer, Walter C. Herlihy, Ph.D., will present at the Biocentury and Thomson Reuters 18th Annual Future Leaders in the Biotech Industry Conference on Friday April 15th, 2011 at 2:30 p.m. EDT, at the Millennium Broadway Hotel in New York City. During the presentation, Dr. Herlihy will discuss Repligen’s development goals for this current fiscal year. A live audio webcast of the presentation will be available via Repligen’s website at www.repligen.com and will be archived for 30 days following the presentation.

MORE ON THIS TOPIC